{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T22:42:06Z","timestamp":1772145726398,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.neuropharm.2013.06.020","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T22:32:20Z","timestamp":1372977140000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors"],"prefix":"10.1016","volume":"75","author":[{"given":"B.D.","family":"Harvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.","family":"Siok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Volfson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Haj\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.06.020_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.11.018","article-title":"Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture","volume":"603","author":"Ahnaou","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib2","first-page":"698","article-title":"Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5","volume":"47","author":"Ametamey","year":"2006","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib3","first-page":"247","article-title":"Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688","volume":"48","author":"Ametamey","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01935-6","article-title":"In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)","volume":"473","author":"Anderson","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00213-005-2211-9","article-title":"The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison","volume":"179","author":"Ballard","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib61","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/mds.23616","article-title":"AFQ056 treatment of levodopa-induced dyskinesias: results of\u00a02 randomized controlled trials","volume":"26","author":"Berg","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/sleep\/22.4.423","article-title":"Comparison of MK-801 and sleep deprivation effects on NREM, REM, and waking spectra in the rat","volume":"22","author":"Campbell","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib7","first-page":"464","article-title":"Pharmacological dissociation of EEG and behavior: a basic problem in sleep-wake classification","volume":"14","author":"Coenen","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/mp.2009.57","article-title":"Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes","volume":"15","author":"Elia","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2010.11.009","article-title":"Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats","volume":"95","author":"Fowler","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib10","first-page":"144","article-title":"Phase II double-bind controlled study of a new anxiolytic, fenobam (McN-3377) vs placebo","volume":"27","author":"Friedmann","year":"1980","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib11","unstructured":"Gasparini, F., Auberson, Y., Ofner, S., 2003. Acetylene Derivatives Having mGluR 5 Antagonistic Activity. In: Organization, W. I. P., (Ed). Novartis AG; Novartis Pharma GmBH; Gasparini, F., Auberson, Y., Ofner, S."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/npp.2008.140","article-title":"mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats","volume":"34","author":"Gass","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2869.2011.00914.x","article-title":"Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression","volume":"20","author":"Goder","year":"2011","journal-title":"J.\u00a0Sleep Res."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/1073858410377064","article-title":"Slow wave activity during sleep: functional and therapeutic implications","volume":"16","author":"Greene","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.parkreldis.2011.01.008","article-title":"The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys","volume":"17","author":"Gregoire","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/sleep\/28.2.187","article-title":"A\u00a0double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo","volume":"28","author":"Hindmarch","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuropharm.2012.04.007","article-title":"Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression","volume":"66","author":"Hughes","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib18","doi-asserted-by":"crossref","first-page":"15951","DOI":"10.1523\/JNEUROSCI.3663-10.2010","article-title":"Glutamatergic neurons of the mouse medial septum and diagonal band of Broca synaptically drive hippocampal pyramidal cells: relevance for hippocampal theta rhythm","volume":"30","author":"Huh","year":"2010","journal-title":"J.\u00a0Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2013.06.020_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.55","article-title":"Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor\/ataxia syndrome and fragile X-associated primary ovarian insufficiency","volume":"19","author":"Jacquemont","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib19","doi-asserted-by":"crossref","first-page":"102mr102","DOI":"10.1126\/scitranslmed.3002804","article-title":"Translating glutamate: from pathophysiology to treatment","volume":"3","author":"Javitt","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","article-title":"Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib63","first-page":"99","article-title":"Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat","volume":"291","author":"Kinney","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S1461145710000271","article-title":"Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia","volume":"14","author":"Kiss","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fpsyt.2011.00014","article-title":"Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity","volume":"2","author":"Kiss","year":"2011","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hipo.20299","article-title":"Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats","volume":"17","author":"Kocsis","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000119015","article-title":"Classification of psychotropic drugs based on pharmaco-electrocorticographic studies in vigilance-controlled rats","volume":"28","author":"Krijzer","year":"1993","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib26","first-page":"1095","article-title":"Pregabalin enhances nonrapid eye movement sleep","volume":"299","author":"Kubota","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib27","first-page":"390","article-title":"Evaluation of 11C-ABP688 and 18F-FPEB for imaging mGluR5 receptors in the human brain","volume":"52","author":"Kuwabara","year":"2011","journal-title":"J.\u00a0Nucl Med Meet. Abstracts"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib28","first-page":"95","article-title":"Fenobam \u2013 another anxiolytic","volume":"31","author":"Lapierre","year":"1982","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib29","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.1073\/pnas.0408242101","article-title":"Common scale-invariant patterns of sleep-wake transitions across mammalian species","volume":"101","author":"Lo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2005.09.006","article-title":"Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors","volume":"6","author":"Marino","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FBP.0b013e3282ee82e3","article-title":"Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?","volume":"18","author":"McNaughton","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib32","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1098\/rsta.2011.0082","article-title":"The multiple time scales of sleep dynamics as a challenge for modelling the sleeping brain","volume":"369","author":"Olbrich","year":"2011","journal-title":"Philos. Transact A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2007.04.007","article-title":"Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs","volume":"115","author":"Palucha","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004714-198204000-00010","article-title":"Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study","volume":"2","author":"Pecknold","year":"1982","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","article-title":"Mood disorders: regulation by metabotropic glutamate receptors","volume":"75","author":"Pilc","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0028-3908(03)00137-0","article-title":"Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors","volume":"45","author":"Pisani","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2174\/187152710793361612","article-title":"Group I metabotropic glutamate receptor signalling and its implication in neurological disease","volume":"9","author":"Ribeiro","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-010-8153-1","article-title":"Huntington's disease and Group I metabotropic glutamate receptors","volume":"43","author":"Ribeiro","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/mol.110.067207","article-title":"Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in\u00a0vivo activity in rat behavioral models of anxiolytic and antipsychotic activity","volume":"78","author":"Rodriguez","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib40","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1016\/j.bmcl.2004.05.037","article-title":"5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3\u2032-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity","volume":"14","author":"Roppe","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib41","first-page":"51","article-title":"On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies","volume":"27","author":"Saletu","year":"1989","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib42","first-page":"1","article-title":"Defining the\u00a0translational pharmacology of negative allosteric modulators of the metabotropic glutamate receptor subtype 5 in rats and nonhuman primates","volume":"9","author":"Shaffer","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0006-3223(94)00135-P","article-title":"Effect of pharmacologic treatments on the sleep of depressed patients","volume":"37","author":"Sharpley","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib44","series-title":"Basic Neurochemistry: Molecular, Cellular, and Medical Aspects","author":"Siegel","year":"2006"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1358\/dnp.2005.18.6.927927","article-title":"The role of metabotropic glutamate receptor 5 in learning and memory processes","volume":"18","author":"Simonyi","year":"2005","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2011.07.011","article-title":"Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats","volume":"62","author":"Siok","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuropharm.2008.09.013","article-title":"Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation","volume":"56","author":"Siok","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib48","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0091-3057(01)00702-X","article-title":"Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine","volume":"71","author":"Smith","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib49","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0b013e3182166dc7","article-title":"Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links","volume":"76","author":"Sokol","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib50","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1113\/jphysiol.2003.046847","article-title":"Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity","volume":"551","author":"Sotty","year":"2003","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpsychires.2009.08.013","article-title":"Wake and sleep EEG provide biomarkers in depression","volume":"44","author":"Steiger","year":"2010","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib52","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2967\/jnumed.107.039578","article-title":"Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods","volume":"48","author":"Treyer","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10827-006-9082-x","article-title":"How do glutamatergic and GABAergic cells contribute to synchronization in the medial septum?","volume":"21","author":"Ujfalussy","year":"2006","journal-title":"J.\u00a0Comput. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2006.03.018","article-title":"Metabotropic glutamate receptors and epilepsy","volume":"247","author":"Ure","year":"2006","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jcp.10081","article-title":"Distinct physiological roles of the Gq-coupled metabotropic glutamate receptors Co-expressed in the same neuronal populations","volume":"191","author":"Valenti","year":"2002","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2004.03.017","article-title":"Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats","volume":"47","author":"van Lier","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib57","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hipo.20118","article-title":"Hippocampal theta rhythm: a tag for short-term memory","volume":"15","author":"Vertes","year":"2005","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2013.06.020_bib58","doi-asserted-by":"crossref","first-page":"10670","DOI":"10.1523\/JNEUROSCI.1987-04.2004","article-title":"Interactions between GABAergic and cholinergic processes in the nucleus pontis oralis: neuronal mechanisms controlling active (rapid eye movement) sleep and wakefulness","volume":"24","author":"Xi","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.06.020_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2011.06.011","article-title":"A\u00a0critical test of the hippocampal theta model of anxiolytic drug action","volume":"62","author":"Yeung","year":"2012","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813002888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T05:33:08Z","timestamp":1563341588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813002888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":63,"alternative-id":["S0028390813002888"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}